J M Katz

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts
    J M Katz
    Influenza Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 180:1763-70. 1999
  2. ncbi A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice
    J M Katz
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Vaccine 18:2177-87. 2000
  3. ncbi Immunity to influenza A H9N2 viruses induced by infection and vaccination
    X Lu
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 75:4896-901. 2001
  4. ncbi Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection
    T M Tumpey
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 75:5141-50. 2001
  5. ncbi New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice
    M A Hoelscher
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Pharmacol Ther 82:665-71. 2007
  6. ncbi Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong
    C Buxton Bridges
    Centers for Disease Control and Prevention, Influenza Branch, MS A 32, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Infect Dis 181:344-8. 2000
  7. ncbi The public health impact of avian influenza viruses
    J M Katz
    Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Poult Sci 88:872-9. 2009
  8. ncbi Molecular correlates of influenza A H5N1 virus pathogenesis in mice
    J M Katz
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 74:10807-10. 2000
  9. ncbi Mechanisms of pathogenicity of influenza A (H5N1) viruses in mice
    R A Bright
    Emory University, Atlanta, GA 30329, USA
    Avian Dis 47:1131-4. 2003
  10. ncbi Pathogenesis of and immunity to a new influenza A (H5N1) virus isolated from duck meat
    X H Lu
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, N.E, Atlanta, GA 30333, USA
    Avian Dis 47:1135-40. 2003

Collaborators

Detail Information

Publications17

  1. ncbi Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts
    J M Katz
    Influenza Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 180:1763-70. 1999
    ..In contrast, social exposure to case patients was not associated with H5N1 infection...
  2. ncbi A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice
    J M Katz
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Vaccine 18:2177-87. 2000
    ..These results suggest that the copolymer adjuvant warrants further investigation as a potential adjuvant for use in human vaccination against influenza...
  3. ncbi Immunity to influenza A H9N2 viruses induced by infection and vaccination
    X Lu
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 75:4896-901. 2001
    ..These results have implications for the development of human vaccines against H9N2 viruses, a priority for pandemic preparedness...
  4. ncbi Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection
    T M Tumpey
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 75:5141-50. 2001
    ..These results suggest a strategy of mucosal vaccination that stimulates cross-protection against multiple influenza virus subtypes, including viruses with pandemic potential...
  5. ncbi New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice
    M A Hoelscher
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Pharmacol Ther 82:665-71. 2007
    ..Furthermore, the vaccine-induced humoral and cellular immune responses and protective immunity persisted at least for a year...
  6. ncbi Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong
    C Buxton Bridges
    Centers for Disease Control and Prevention, Influenza Branch, MS A 32, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Infect Dis 181:344-8. 2000
    ..Human-to-human transmission of avian influenza may increase the chances for the emergence of a novel influenza virus with pandemic potential...
  7. ncbi The public health impact of avian influenza viruses
    J M Katz
    Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Poult Sci 88:872-9. 2009
    ..Taken together, such studies provide valuable information with which we can assess the public health risk of avian influenza viruses...
  8. ncbi Molecular correlates of influenza A H5N1 virus pathogenesis in mice
    J M Katz
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 74:10807-10. 2000
    ..Alone or in combination, these specific residues are the likely determinants of virulence of human H5N1 influenza viruses in this model...
  9. ncbi Mechanisms of pathogenicity of influenza A (H5N1) viruses in mice
    R A Bright
    Emory University, Atlanta, GA 30329, USA
    Avian Dis 47:1131-4. 2003
    ..This study demonstrates the importance of extrapulmonary spread and replication, particularly in the brain, for the lethality of H5N1 viruses...
  10. ncbi Pathogenesis of and immunity to a new influenza A (H5N1) virus isolated from duck meat
    X H Lu
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, N.E, Atlanta, GA 30333, USA
    Avian Dis 47:1135-40. 2003
    ..A/Dkmt virus cross-reacted poorly with ferret antisera raised against human H5N1 viruses, but prior infection with A/Dkmt virus protected mice from death after secondary infection with human H5N1 virus...
  11. ncbi A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans
    X Lu
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 73:5903-11. 1999
    ..These results suggests a strategy of vaccine preparedness for rapid intervention in future influenza pandemics that uses antigenically related nonpathogenic viruses as vaccine candidates...
  12. ncbi Current methods for assessing T cell responses to influenza
    J M Katz
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Dev Biol (Basel) 115:85-93. 2003
    ..Although still technically demanding, these modern assays represent important new tools for the quantitative analysis of T cell responses to influenza infection and vaccination...
  13. ncbi Neurological manifestations of avian influenza viruses in mammals
    T Rowe
    Influenza Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop G-16, Atlanta, GA 30333, USA
    Avian Dis 47:1122-6. 2003
    ..However, HK/486 was able to replicate in the brain and induce lethal disease following direct intracerebral inoculation...
  14. ncbi Influenza vaccines generated by reverse genetics
    K Subbarao
    Influenza Branch, Centers for Disease Control and Prevention, Mailstop G-16, 1600 Clifton Road, Atlanta, GA 30333, USA
    Curr Top Microbiol Immunol 283:313-42. 2004
    ..The future of influenza prevention and control lies in the application of this powerful technology for the generation of safe and more effective influenza vaccines...
  15. ncbi Systemic and cellular immunity
    J M Katz
    Influenza Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Dev Biol (Basel) 115:107-9. 2003
  16. ncbi The impact of avian influenza viruses on public health
    J M Katz
    Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, G-16, Atlanta, GA 30333, USA
    Avian Dis 47:914-20. 2003
    ..Such transmission increases the likelihood of reassortment between a currently circulating human virus and an avian virus and thus the creation of a strain with pandemic potential...
  17. ncbi Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects
    L A Pinto
    Experimental Immunology Branch, National Cancer Institute, Bethesda, MD, USA
    J Infect Dis 183:1000-8. 2001
    ..In summary, influenza vaccination can induce an increase in multiple immunologic components that remained impaired in HIV patients...